Search Results

Displaying Results 751-775 of 872 "'VERA'"

Aug 27, 2025, 08:30 ET Hot Melt Extrusion: Accelerating Drug Development for Poorly Soluble APIs, Upcoming Webinar Hosted by Xtalks

www.xtalks.com/why-host-a-webinar/ Contact:Vera KovacevicTel: +1 (416) 977-6555 x371Email: [email protected]

More news about: Xtalks


Aug 27, 2025, 08:30 ET Scalable VHH and Peptide Secretion Platform Using C. glutamicum, Upcoming Webinar Hosted by Xtalks

www.xtalks.com/why-host-a-webinar/ Contact:Vera KovacevicTel: +1 (416) 977-6555 x371Email: [email protected]

More news about: Xtalks


Aug 27, 2025, 08:30 ET Advancing the Next Parkinson's Disease Breakthrough: Keys to Successful Clinical Trials, Upcoming Webinar Hosted by Xtalks

www.xtalks.com/why-host-a-webinar/ Contact:Vera KovacevicTel: +1 (416) 977-6555 x371Email: [email protected]

More news about: Xtalks


Aug 27, 2025, 08:30 ET Applying a Holistic Digital Endpoint Strategy in the Development of Congestive Heart Failure Treatments, Upcoming Webinar Hosted by Xtalks

www.xtalks.com/why-host-a-webinar/ Contact:Vera KovacevicTel: +1 (416) 977-6555 x371Email: [email protected]

More news about: Xtalks


Aug 26, 2025, 08:30 ET p-Tau 205 and p-Tau 212: Emerging Biomarkers for Alzheimer's Disease Research, Upcoming Webinar Hosted by Xtalks

www.xtalks.com/why-host-a-webinar/ Contact:Vera KovacevicTel: +1 (416) 977-6555 x371Email: [email protected]

More news about: Xtalks


Aug 26, 2025, 08:30 ET Advancing ADC Design Through Site-Specific Conjugation and Stable Linkers, Upcoming Webinar Hosted by Xtalks

www.xtalks.com/why-host-a-webinar/ Contact:Vera KovacevicTel: +1 (416) 977-6555 x371Email: [email protected]

More news about: Xtalks


Aug 26, 2025, 08:30 ET ADCs in Oncology Trials: Practical Strategies for Clinical Development Success, Upcoming Webinar Hosted by Xtalks

www.xtalks.com/why-host-a-webinar/ Contact:Vera KovacevicTel: +1 (416) 977-6555 x371Email: [email protected]

More news about: Xtalks


Aug 25, 2025, 16:08 ET Rosen Law Firm Encourages Vera Bradley, Inc. Investors to Inquire About Securities Class Action Investigation - VRA

Vera Bradley, Inc. (NASDAQ: VRA) resulting from allegations that Vera Bradley may have issued materially misleading business information to the investing public. So What: If you purchased Vera Bradley securities

More news about: THE ROSEN LAW FIRM, P. A.


Aug 25, 2025, 10:01 ET IDEMIA Public Security and Sopra Steria Launch Successful Go-Live of shared Biometric Matching System with eu-LISA

www.idemia.com. Media contact:Genevieve de VeraIDEMIA Public Security(978) [email protected]

More news about: IDEMIA


Aug 25, 2025, 08:30 ET Xtalks Launches Xtalks Open Mic to Amplify Authentic Voices Across the Life Sciences

in through Xtalks Open Mic. We've already had such a great response, and I can't wait to review even more submissions," said Vera Kovacevic, Editor-in-Chief of Xtalks. An Open Invitation to the Life Sciences Community Xtalks Open Mic is

More news about: Xtalks


Aug 25, 2025, 08:30 ET AI in Regulatory Medical Writing: Balancing Innovation with Human Expertise, Upcoming Webinar Hosted by Xtalks

www.xtalks.com/why-host-a-webinar/ Contact:Vera KovacevicTel: +1 (416) 977-6555 x371Email: [email protected]

More news about: Xtalks


Aug 25, 2025, 08:30 ET ADC Development: Early On- and Off-Target Testing to Fail Fast, Upcoming Webinar Hosted by Xtalks

www.xtalks.com/why-host-a-webinar/ Xtalks Media Contact:Vera KovacevicTel: +1 (416) 977-6555 x371Email: [email protected]

More news about: Xtalks


Aug 25, 2025, 08:00 ET ITF Therapeutics Announces Publication of Positive Long-Term Data Reinforcing Givinostat Efficacy and Safety as a Treatment for Duchenne Muscular Dystrophy

Italfarmaco's rare disease unit includes programmes in Duchenne muscular dystrophy, Becker muscular dystrophy, amyotrophic lateral sclerosis and polycythaemia vera. North America Media enquiries:

More news about: ITF Therapeutics LLC


Aug 21, 2025, 12:45 ET Harnessing the Power of Laboratory Data to Optimize Trial Design, Site Identification and Patient Recruitment, Upcoming Webinar Hosted by Xtalks

www.xtalks.com/why-host-a-webinar/ Contact:Vera KovacevicTel: +1 (416) 977-6555 x371Email: [email protected]

More news about: Xtalks


Aug 21, 2025, 12:30 ET Biomedical Polyurethane Technologies for Medical Device Innovation, Upcoming Webinar Hosted by Xtalks

www.xtalks.com/why-host-a-webinar/ Contact:Vera KovacevicTel: +1 (416) 977-6555 x371Email: [email protected]

More news about: Xtalks


Aug 21, 2025, 10:17 ET No Gray Quick Fix Named Finalist in 2025 CEW Beauty Awards

quick, natural-looking results.Formula & Benefits: Botanical Ingredients — infused with Aloe Vera and Rosemary Leaf Extract to nourish the scalp.Frizz Control + Color Fill — tames flyaways and fills sparse spots with buildable coverage.No

More news about: DEVELOPLUS, INC.


Aug 21, 2025, 09:00 ET Vera Whole Health and Castlight Health Join Forces with Aligned Marketplace to Expand High-Quality Care Solutions

data-driven insights and multifunctional care teams, Vera improves health outcomes, reduces total cost of care and consistently achieves a best-in-class member experience. Vera currently owns and operates care centers in 11 states across the U.S. In 2022, Vera merged with Castlight to create apree health family

More news about: Castlight Health, Inc.


Aug 21, 2025, 08:30 ET Multidomain Biologics: Bioanalytical Strategies and Insights, Upcoming Webinar Hosted by Xtalks

www.xtalks.com/why-host-a-webinar/ Contact:Vera KovacevicTel: +1 (416) 977-6555 x371Email: [email protected]

More news about: Xtalks


Aug 21, 2025, 08:18 ET Huawei deve revelar novos vestíveis, tablets e telefones em Paris em 19 de setembro

-- A Huawei realizará o lançamento do produto inovador "Ride the Wind" em 19 de setembro em Paris, França. O evento verá o lançamento da novíssima série HUAWEI WATCH GT 6, que oferece recursos de fitness e saúde de ponta, bem como produtos altamente esperados para smartphones

More news about: HUAWEI


Aug 21, 2025, 05:15 ET Angelalign Technology niega la infracción de patente y promete una enérgica defensa

clientes, han impulsado un impresionante crecimiento global para Angel, que se prevé que continúe. "Anticipamos que nuestro crecimiento no se verá afectado significativamente por las demandas", afirmó Hirschland. "Esperamos usar las demandas para difundir la historia de éxito de Angel y atraer

More news about: Angel Aligner


Aug 20, 2025, 17:31 ET HDAC Inhibitors Market Sees Upward Trajectory Across the 7MM During the Forecast Period (2025-2034) Driven by Innovation in Cancer Therapies | DelveInsight

DUVYZAT. The drug is also being evaluated in other indications: Phase III trial in Becker muscular dystrophy (BMD) and Phase II trial in polycythemia vera. HIYASTA (HBI-8000) is an epigenetic immunomodulator approved for several indications, including use as monotherapy for certain subtypes of relapsed

More news about: DelveInsight Business Research, LLP


Aug 19, 2025, 12:56 ET Air Regulators Turned Lobbyists Lead To False Conclusions About Need For Carbon Capture in Cap-and-Trade, Consumer Watchdog Tells Legislative Leaders

Tradesman Advisors six years later. In the 2023-2024 legislative cycle, Tradesman Advisors represented the Verified Emissions Reduction Association (VERA) that Costantino also directs. The trade association represents developers of carbon offsets and has developed an

More news about: Consumer Watchdog


Aug 19, 2025, 08:30 ET Accelerating Data Entry for Non-GLP Pathology Studies, Upcoming Webinar Hosted by Xtalks

www.xtalks.com/why-host-a-webinar/ Contact:Vera KovacevicTel: +1 (416) 977-6555 x371Email: [email protected]

More news about: Xtalks


Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.